NCT06837597View on ClinicalTrials.gov

Jianzhong Qushi in Chronic RRI

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

January 31, 2029

Conditions
Chronic Radiation Proctitis
Interventions
DRUG

Jianzhong Qushi Formula

Jianzhong Qushi Formula (A Chinese traditional formula, approved by Chinese Patent, No. ZL202210097886.0)

DRUG

Placebo

A simulated Chinese medicine placebo, with similar appearance and smell to Jianzhong Qushi Formula.

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER